Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 110 participants.

Also called NCT02275260

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02275260
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia, Germany, Hungary, Netherlands, Switzerland (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02275260. Allocation not applicable; no masking; primary purpose screening. Start 2014-12 (actual); primary completion 2017-02-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Cerebral Diffusion-Weighted Magnetic Resonance Imaging
Intervention (Device)
Transesophageal Echocardiography
Intervention (Other)
Paperbased neurocognitive testing
Lead sponsor
Biotronik SE & Co. KG (class: industry)
Collaborator
University Hospital Heidelberg (class: other)

Record details

Record id
cardio:ct-nct02275260
Content hash
864c03a3316ee5c650b0104b82a3a8fc949a501f4ae8b4741587637d75c2e61d